CZD 3.13% 9.3¢ calzada limited

calzada's npt dressing - immediate opportunity, page-16

  1. 5,260 Posts.
    lightbulb Created with Sketch. 242
    Graeme and all...

    The issue with Dr. Greenwood's 2013 ABA papers has been clarified:

    "Dr. Greenwood presented three papers at the ABA this year..."

    These are the two papers on NovoSorb trials in humans already released and a third paper on progress with the CCS.

    "...the content of the CCS presentation should be made available next week."

    I expect the CCS paper will likely be released on Monday.
 
watchlist Created with Sketch. Add CZD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.